1/14
Looks like no tags are added yet.
CYP1A2 Traits
Narrow, Flat, planar, thin molecules with aromatic rings.
CYP1A2 Interactions
Aromatic Ring, Hydrophobic, Hydrogen bonding.
CYP1A2 Substrates
Caffeine, tacrine, and phenacetin.
CYP2C9 Traits
Intermediate size and acidic; hydrogen-bond acceptor.
CYP2C9 Interactions
Phenol O-demethylation.
Benzylic Carbon Oxidation
Sulfur Oxidations
N-Dealkylation
Aromatic Hydoxylation
Oxidation of atoms at end/middle of long molecule
CYP2C9 substrates
Ibuprofen, NSAIDs, fluoxetine, losartan, phenytoin, tolbutamide, torsemide, and S-warfarin.
CYP2D6 Traits
Intermediate size and basic; hydrogen-bond donor.
CYP2D6 Interactions
Phenol O-demethylation.
Benzylic Carbon Oxidation
O-Demathylation
Oxidation of atoms at end or middle of long molecule
CYP2D6 substrates
Amitriptyline, nortriptyline, paroxetine, fluoxetine, metoprolol, propranolol, lidocaine, flecainide, haloperidol, venlafaxine, and thioridazine.
CYP2C8 Traits
Large, with a wide region near the oxidation site.
CYP2C8 Interaction
Hydrophobic
Oxidation of Atoms at end/middle of long molecule
CYP2C8 substrates
Imatinib, loperamide, montelukast, paclitaxel, pioglitazone, repaglinide, and rosiglitazone.
CYP3A4 Traits
Large, with a narrow region near the oxidation site.
CYP3A4 interactions
N-Dealkylation
Sulfur Oxidation
Benzylic and Allylic Carbon Hydroxylation
Aromatic Carbon Hydroxylation
Oxidation of atoms near end of molecule.
CYP3A4 substrates
Amiodarone, cocaine, verapamil, quinidine, steroids, midazolam, cyclosporine, terfenadine, tamoxifen, and diltiazem.